$308.15
-3.05-0.98%
At Close: -
$308.15
00.00%
After Hours: Sep 20, 4:07 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for West Pharmaceutical Servs (WST) was reported on July 25, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $6.35 to $6.65, compared to the estimated EPS of $7.74. Additionally, West Pharmaceutical Servs forecasted revenue between $2.87B and $2.90B for the quarter.
Browse guidance and forecast on all stocks.